Vident Advisory’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $130K | Buy |
22,687
+10,230
| +82% | +$58.6K | ﹤0.01% | 1549 |
|
|
2025
Q1 | $102K | Buy |
+12,457
| New | +$102K | ﹤0.01% | 1506 |
|
|
2024
Q4 | – | Sell |
-130,108
| Closed | -$1.39M | – | 1483 |
|
|
2024
Q3 | $1.39M | Buy |
130,108
+21,229
| +19% | +$227K | 0.04% | 520 |
|
|
2024
Q2 | $1.08M | Buy |
108,879
+28,842
| +36% | +$286K | 0.03% | 569 |
|
|
2024
Q1 | $943K | Buy |
80,037
+13,202
| +20% | +$156K | 0.02% | 594 |
|
|
2023
Q4 | $948K | Buy |
66,835
+50,741
| +315% | +$720K | 0.02% | 573 |
|
|
2023
Q3 | $196K | Buy |
+16,094
| New | +$196K | 0.01% | 1123 |
|